A Novel ATM Pathogenic Variant in an Italian Woman with Gallbladder Cancer
Open Access
- 22 February 2021
- Vol. 12 (2), 313
- https://doi.org/10.3390/genes12020313
Abstract
Gallbladder carcinoma (GBC) is one of the most aggressive malignancies with poor prognosis and a high fatality rate. The disease presents in advanced stages where the treatment is ineffective. Regarding GBC pathogenesis, as with other neoplasia, this tumor is a multifactorial disorder involving different causative factors such as environmental, microbial, metabolic, and molecular. Genetic alterations can be germline or somatic that involving proto-oncogenes, tumor suppressor genes, cell cycle genes, and growth factors. The ataxia telangiectasia mutated (ATM) gene, coding a serine/threonine kinase involved in the early stages of the homologous recombination (HR) mechanism, is one of the most altered genes in GBC. Here, we present the molecular characterization of a novel germline ATM large genomic rearrangement (LGR) identified by next-generation sequencing (NGS) analysis in an Italian woman diagnosed with metastatic GBC at the age of 55. The results underline the importance of expanding the NGS approach in gallbladder cancer in order to propose new molecular markers of predisposition and prognosis exploitable by novel targeted therapies that may improve the response of patients with ATM-deficient cancers.This publication has 33 references indexed in Scilit:
- SF3B1 mutations in chronic lymphocytic leukemiaBlood, 2013
- Targeted Next-generation Sequencing of Advanced Prostate Cancer Identifies Potential Therapeutic Targets and Disease HeterogeneityEuropean Urology, 2013
- Exome sequencing identifies nonsegregating nonsense ATM and PALB2variants in familial pancreatic cancerHuman Genomics, 2013
- Pancreatic cancer genomes reveal aberrations in axon guidance pathway genesNature, 2012
- ATM Mutations in Patients with Hereditary Pancreatic CancerCancer Discovery, 2012
- Association between ATM polymorphisms and cancer risk: a meta-analysisMolecular Biology Reports, 2011
- Somatic mutations affect key pathways in lung adenocarcinomaNature, 2008
- Cancer Risks and Mortality in Heterozygous ATM Mutation CarriersJNCI Journal of the National Cancer Institute, 2005
- Association of P53, P16, and Vascular Endothelial Growth Factor Protein Expressions with The Prognosis and Metastasis of Gallbladder CancerJournal of the American College of Surgeons, 2001
- Incidence of Cancer in 161 Families Affected by Ataxia–TelangiectasiaThe New England Journal of Medicine, 1991